Pregnancy Exposures and Outcomes in Women with Psoriasis Treated with Risankizumab: A Cohort Study Utilizing Large Electronic Healthcare Databases with Mother-Baby Linkage in the United States

16/03/2021
14/03/2024
EU PAS number:
EUPAS39775
Study
Ongoing
Documents
Study protocol
Initial protocol
English (177.15 KB - PDF) View document
Updated protocol
English (150.93 KB - PDF) View document
Study results
Study report
Other information